1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Transplant, Application, Technology, End User, and Region - Analysis and Forecast, 2021-2031

Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Transplant, Application, Technology, End User, and Region - Analysis and Forecast, 2021-2031

  • October 2021
  • 228 pages
  • ID: 6169593
  • Format: PDF
  • BIS Research

Summary

Table of Contents

Global Organ Transplant Diagnostics Market to Reach $9,663.0 Million by 2031

Market Report Coverage - Organ Transplant Diagnostics

Market Segmentation

• Offering - Products (Kits and Assays and Consumables) and Services
• Transplant - Solid Organ Transplant and Stem Cell Transplant
• Application - Diagnostics (Donor Testing and Recipient Testing) and Translational Research
• Technology - Molecular Technologies, Serology, Flow Cytometry, and Other Technologies
• End User - Hospitals and Transplant Centers, Academic and Research Institutions, Reference Laboratories, and Other End Users

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, France, U.K., Italy, Spain, Switzerland, and Rest-of-Europe
• Asia-Pacific – China, India, Japan, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Market Growth Drivers

• Rising Number of Organ Transplant Procedure
• Strategic Initiatives by Key Market Players
• Favorable Regulatory Scenario

Market Challenges

• High Cost of Organ Transplant Procedure and Diagnostics
• Lack of Knowledge Dissemination and Reluctance Toward Organ Transplants

Market Opportunities

• Technological Advancement in Transplant Diagnostics
• Increasing Awareness Regarding Transplants in High potential Market

Key Companies Profiled

Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMérieux S.A., CareDx, Inc., ARUP Laboratories, Abbott Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific, Illumina, Inc., OPKO Health, Novacyt Group, Immucor, Inc.

Key Questions Answered in this Report:
• How is organ transplant diagnostics revolutionizing the field of transplant care?
• What are the major market drivers, challenges, and opportunities in the global organ transplant diagnostics market?
• What are the underlying structures resulting in the emerging trends within the global organ transplant diagnostics market?
• How did the COVID-19 pandemic impact the global organ transplant diagnostics ecosystem?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of organ transplant diagnostics?
• What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region?

• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Offering (products and services)
o Transplant (solid organ transplant and stem cell transplant)
o Application (diagnostics and translation research)
o Technology (molecular technologies, serology, flow cytometry and other technologies)
o End User (hospitals and transplant centers, academic and research institutions, and reference laboratories)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the organ transplant diagnostics companies in the region of their operation?
• Who are the leading players with significant offerings in the global organ transplant diagnostics market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

Our healthcare experts have found the organ transplant diagnostics industry to be one of the most rapidly evolving and dynamic markets, and the global market for organ transplant diagnostics is predicted to grow at a CAGR of 10.92% over the forecast period of 2021-2031. The market is driven by certain factors, which include rising number of organ transplant procedures, strategic initiatives by key market players, and favorable regulatory scenarios.

Currently, the organ transplant diagnostics industry is witnessing an upsurge due to the rising number of organ transplant procedures, strategic initiatives by key market players, and favorable regulatory scenarios are some of the critical factors which are expected to bolster the market growth.

Furthermore, biotechnology companies are focusing on the development of robust organ transplant diagnostics solutions for applications, including diagnostics and translational research, further supporting transplant physicians and researchers to unravel insights pertaining to the intricacies present in the field of transplant care. The development of organ transplant diagnostic products and services enabled transplant physicians to establish effective strategies for organ donor screening and recipient surveillance, further offering value-based care.

Within the research report, the market is segmented on the basis of offering, transplant, application, technology, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the number of organ transplant procedures worldwide has created a buzz among the biotechnology companies to further invest in the development of innovative organ transplant diagnostic tools, further aiding transplant physicians to offer value-based clinical outcomes to transplant patients. Due to the expansive product portfolio and massive geographical presence, Thermo Fisher Scientific Inc. has been the leading player in the organ transplant diagnostics ecosystem.

On the basis of region, North America holds the largest share of the organ transplant diagnostics market due to the presence of well-established guidelines regarding transplant diagnostics, presence of legacy companies undertaking key business strategies, rising number of organ transplants, and increasing adoption of products based on advanced molecular technologies by the transplant physicians, among others.Further, increasing focus on research pertaining to the discovery of novel transplant-associated biomarkers is also expected to support the growth of the North America organ transplant diagnostics market.

Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2021-2031.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• U.K.
• Switzerland
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest-of-Latin America (RoLA)
• Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021

  • $ 2000
  • September 2021
  • 116 pages

Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021 Summary Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021 provides an overview of the ...

  • World
  • Cell Therapy
  • Transplantation
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on